Sodium 4-Aminosalicylate Dihydrate CAS 6018-19-5 Purity >99.0% (HPLC) (T)

Sodium 4-Aminosalicylate Dihydrate (CAS: 6018-19-5) is an antibiotic used to treat tuberculosis via NF-κB inhibition and free radical scavenging. Antibacterial, tuberculostatic. Sodium 4-Aminosalicylate Dihydrate is commonly used as an anti-tuberculosis drug. It is suitable for pulmonary and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis. Because tuberculosis bacilli can quickly develop resistance to it when used alone, it is often combined with streptomycin and isoniazid, and is mainly used as a second-line anti-tuberculosis drug. When heated to decomposition it emits toxic fumes of NO, and Na2O. It is suitable for pulmonary and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis. Sodium para-aminosalicylate is effective only against mycobacteria and not against nontuberculous mycobacteria. Resistance can develop rapidly when used alone, so it must be combined with other anti-TB drugs. Streptomycin and isoniazid, when combined with them, can delay the development of drug resistance of Mycobacterium tuberculosis to the two drugs. It is mainly used as a second-line anti-tuberculosis drug. It can also be used for hyperthyroidism, and it is more suitable for patients with hyperthyroidism and tuberculosis. When the iodine agent is ineffective and affects the operation, it can be taken for a short period of time to create conditions for the operation. Intravenous infusion is generally used in severe cases such as tuberculous meningitis.